Harvard Apparatus Regenerative Technology Inc. announced that it has entered into Securities Purchase Agreements with certain investors to issue an aggregate of 367,767 shares of common stock at a purchase price of $4.03 per share for the gross proceeds of $1,482,101.01 on April 15, 2024. The shares are issued without registration under the Securities Act in reliance on the exemptions provided by Section 4(a)(2) of the Securities Act as transactions not involving a public offering and Rule 506 promulgated under and/or Regulation D thereunder.
Harvard Apparatus Regenerative Technology Inc.
Equities
HRGN
US09074M2026
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.46 USD | +0.82% | +2.93% | -50.70% |
1st Jan change | Capi. | |
---|---|---|
-50.70% | 34.93M | |
+7.84% | 218B | |
+7.35% | 183B | |
+13.04% | 134B | |
+26.03% | 106B | |
-1.33% | 61.12B | |
+4.81% | 50.89B | |
+0.30% | 40.3B | |
+2.78% | 35.53B | |
+26.14% | 32.05B |
- Stock Market
- Equities
- HRGN Stock
- News Harvard Apparatus Regenerative Technology Inc.
- Harvard Apparatus Regenerative Technology Inc. announced that it expects to receive $1.482101 million in funding